Literature DB >> 18442127

The distinctive movement disorder of ovarian teratoma-associated encephalitis.

Timothy J Kleinig1, Philip D Thompson, Walid Matar, Andrew Duggins, Thomas E Kimber, John G Morris, Christopher S Kneebone, Peter C Blumbergs.   

Abstract

The movement disorder observed in four cases of ovarian teratoma associated encephalitis is described. The illness began with neuropsychiatric symptoms and was followed by prolonged unresponsiveness, respiratory failure, and autonomic instability. The movement disorder consisted of semirhythmic repetitive bulbar and limb movements and persisted during prolonged periods of unresponsiveness, diminishing as awareness returned. The characteristics of the movement disorder differed from recognized dyskinesias. It is suggested that interruption of forebrain corticostriatal inputs by anti-N-methyl-D-aspartate (NMDA) receptor antibodies removes tonic inhibition of brainstem pattern generators releasing primitive patterns of bulbar and limb movement. Recognition of the distinctive movements should prompt a search for an ovarian teratoma since the condition is responsive to tumor resection and immunomodulation. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18442127     DOI: 10.1002/mds.22073

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  39 in total

1.  Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.

Authors:  L C Wong-Kisiel; T Ji; D L Renaud; S Kotagal; M C Patterson; J Dalmau; K J Mack
Journal:  Neurology       Date:  2010-05-11       Impact factor: 9.910

Review 2.  [Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture].

Authors:  H Prüss; J Dalmau; V Arolt; K-P Wandinger
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

3.  Segmental Dystonia in the Context of Dextromethorphan Abuse: A New Cause of Delayed Onset Drug-Induced Dystonia?

Authors:  Thomas E Kimber; Philip D Thompson
Journal:  Mov Disord Clin Pract       Date:  2015-03-28

Review 4.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

Review 5.  Movement disorders in paraneoplastic and autoimmune disease.

Authors:  Jessica Panzer; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

6.  Autoimmune Encephalitis.

Authors:  Frank Leypoldt; Klaus-Peter Wandinger; Christian G Bien; Josep Dalmau
Journal:  Eur Neurol Rev       Date:  2013

7.  Current approaches to the treatment of paraneoplastic encephalitis.

Authors:  Wolfgang Grisold; Bruno Giometto; Roberta Vitaliani; Stefan Oberndorfer
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 8.  Encephalitis and antibodies to synaptic and neuronal cell surface proteins.

Authors:  Eric Lancaster; Eugenia Martinez-Hernandez; Josep Dalmau
Journal:  Neurology       Date:  2011-07-12       Impact factor: 9.910

9.  Isolated hemidystonia associated with NMDA receptor antibodies.

Authors:  Ignacio Rubio-Agustí; Josep Dalmau; Teresa Sevilla; María Burgal; Eduardo Beltrán; Luís Bataller
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

10.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.